Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III StudyTaishi Hata, Hidetoshi Eguchi, Yuko Ohno et al.|The Oncologist|2021Cited by 8
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal CancerJunichi Nishimura, Masaki Mori, Junichi Hasegawa et al.|Journal of the Anus Rectum and Colon|2020Cited by 2
Randomized phase II study of S-1 dosing schedule for resected colorectal cancerChu Matsuda, Masaki Mori, Mamoru Uemura et al.|BMC Cancer|2015Cited by 2
A twice-daily or a three-times-daily tegafur-uracil and leucovorin calcium regimen as adjuvant therapy in patients with resected colorectal cancer: A phase III study.Kazuya Iwamoto, Hidetoshi Eguchi, Taishi Hata et al.|Journal of Clinical Oncology|2022Cited by 0
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of adjuvant XELOX in Japanese patients Taishi Hata, Hidetoshi Eguchi, Katsuki Danno et al.|Research Square|2024Cited by 0